Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2.59M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
3.97M
-
Shares change
-
+736K
-
Total reported value, excl. options
-
$893K
-
Value change
-
-$204K
-
Number of buys
-
3
-
Number of sells
-
-10
-
Price
-
$0.23
Significant Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q4 2024
25 filings reported holding APTO - Aptose Biosciences Inc. - Common Shares as of Q4 2024.
Aptose Biosciences Inc. - Common Shares (APTO) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.97M shares
.
Largest 10 shareholders include Bleichroeder LP (2.5M shares), Sigma Planning Corp (703K shares), DRW Securities, LLC (593K shares), UBS Group AG (57.8K shares), HRT FINANCIAL LP (43.1K shares), Annandale Capital, LLC (26.7K shares), Cetera Investment Advisers (19.2K shares), TWO SIGMA SECURITIES, LLC (11.4K shares), MORGAN STANLEY (5.5K shares), and US BANCORP \DE\ (2.02K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.